Literature DB >> 17976534

Ethanol stimulates bile acid formation in primary human hepatocytes.

Lisa-Mari Nilsson1, Jan Sjövall, Stephen Strom, Karl Bodin, Greg Nowak, Curt Einarsson, Ewa Ellis.   

Abstract

The conversion of cholesterol to bile acids is a key pathway for elimination of cholesterol from the body, thereby reducing the risk of arteriosclerosis. Moderate consumption of ethanol has been shown to have preventive effects on cardiovascular disease and decrease the risk of gallstone formation. In the present study primary human hepatocytes were used to investigate if ethanol affected bile acid synthesis. Hepatocytes were prepared from donor liver (n=11) and treated with ethanol, 7.7 or 50 mM, for 24 h. mRNA levels for enzymes in bile acid synthesis pathways were studied and bile acid synthesis was analyzed. Treatment with 7.7 mM ethanol increased cholic acid synthesis by 20% and treatment with 50 mM ethanol up-regulated cholic acid formation by 60%. The synthesis of cholic acid increased more than that of chenodeoxycholic acid, indicating that the classical pathway for bile acid synthesis was up-regulated. Increased bile acid levels in the cells treated with ethanol were seen after approximately 20 h. mRNA expression of CYP7A1, CYP27A1, and CYP8B1 in the hepatocytes was not affected by alcohol exposure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17976534     DOI: 10.1016/j.bbrc.2007.10.039

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Engineered three-dimensional liver mimics recapitulate critical rat-specific bile acid pathways.

Authors:  Christopher J Detzel; Yeonhee Kim; Padmavathy Rajagopalan
Journal:  Tissue Eng Part A       Date:  2010-12-19       Impact factor: 3.845

Review 2.  Physiological and molecular biochemical mechanisms of bile formation.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

3.  Effect of iron on cholesterol 7α-hydroxylase expression in alcohol-induced hepatic steatosis in mice.

Authors:  Huan Liang; Hui Huang; Pei-Zhu Tan; Ying Liu; Jun-Hui Nie; Yi-Tong Zhang; Kai-Li Zhang; Yan Diao; Qi He; Bao-Yu Hou; Ting-Ting Zhao; Yan-Ze Li; Gui-Xiang Lv; Ki-Young Lee; Xu Gao; Ling-Yun Zhou
Journal:  J Lipid Res       Date:  2017-05-23       Impact factor: 5.922

Review 4.  Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.

Authors:  Grayson W Way; Kaitlyn G Jackson; Shreya R Muscu; Huiping Zhou
Journal:  Cells       Date:  2022-04-18       Impact factor: 7.666

5.  Colonic inflammation and secondary bile acids in alcoholic cirrhosis.

Authors:  Genta Kakiyama; Phillip B Hylemon; Huiping Zhou; William M Pandak; Douglas M Heuman; Dae Joong Kang; Hajime Takei; Hiroshi Nittono; Jason M Ridlon; Michael Fuchs; Emily C Gurley; Yun Wang; Runping Liu; Arun J Sanyal; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-03       Impact factor: 4.052

6.  FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice.

Authors:  Arvin Iracheta-Vellve; Charles D Calenda; Jan Petrasek; Aditya Ambade; Karen Kodys; Luciano Adorini; Gyongyi Szabo
Journal:  Hepatol Commun       Date:  2018-10-15

7.  Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases.

Authors:  Wenkuan Li; Jawaher Abdullah Alamoudi; Nagsen Gautam; Devendra Kumar; Macro Olivera; Yeongjin Gwon; Sandeep Mukgerjee; Yazen Alnouti
Journal:  Int J Hepatol       Date:  2022-03-30

Review 8.  Role of farnesoid X receptor and bile acids in alcoholic liver disease.

Authors:  Sharon Manley; Wenxing Ding
Journal:  Acta Pharm Sin B       Date:  2015-03-09       Impact factor: 11.413

9.  Hepatic cannabinoid receptor type 1 mediates alcohol-induced regulation of bile acid enzyme genes expression via CREBH.

Authors:  Dipanjan Chanda; Yong-Hoon Kim; Tiangang Li; Jagannath Misra; Don-Kyu Kim; Jung Ran Kim; Joseph Kwon; Won-Il Jeong; Sung-Hoon Ahn; Tae-Sik Park; Seung-Hoi Koo; John Y L Chiang; Chul-Ho Lee; Hueng-Sik Choi
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.